HOME / RESOURCES / BEST PRACTICES

Best Practices in AMT

Evidence-based protocols and clinical guidance for optimal amniotic membrane therapy outcomes.

Aurora

Aurora post-procedure protocol

Topical antibioticFluoroquinolone QID for duration of wear

Topical steroidPrednisolone acetate 1% QID or loteprednol 0.5% QID

Lubricating dropsPreservative-free artificial tears Q1-2H as needed

Wear duration5–7 days typical; assess at follow-up

Follow-up timingDay 5–7 for removal assessment; sooner if symptoms worsen

Activity restrictionsAvoid rubbing, swimming, and contact lens wear during treatment

Eclipse

Bandage contact lensPlace over Eclipse after application; remove at follow-up

Topical antibioticFluoroquinolone QID until re-epithelialization confirmed

Topical steroidPrednisolone acetate 1% QID; taper after closure

Lubricating dropsPreservative-free artificial tears Q1-2H

Follow-up timingDay 5–7; confirm tissue dissolution and epithelial closure

BCL removalRemove bandage contact lens at follow-up once closure confirmed

All products

Set expectations before applicationExplain expected blurring (Aurora), mild discomfort, and wear duration before the procedure

Written post-procedure instructionsProvide written drop schedule and activity restrictions at every visit

Symptom escalation criteriaInstruct patients to call immediately for increased pain, discharge, or sudden vision change

Follow-up confirmationConfirm follow-up appointment before the patient leaves the office

Eclipse

Preferred BCLHigh-Dk silicone hydrogel; avoid low-Dk lenses over AMT

Diameter selectionBCL diameter should extend 1–2mm beyond Eclipse tissue edge

Fit assessmentConfirm BCL movement and centration after placement; refit if tissue displaces

The Ophthalogix clinical team can review your post-procedure protocol and provide case-specific guidance.